Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AXITINIB Cause Disseminated intravascular coagulation? 10 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Disseminated intravascular coagulation have been filed in association with AXITINIB (INLYTA). This represents 0.1% of all adverse event reports for AXITINIB.

10
Reports of Disseminated intravascular coagulation with AXITINIB
0.1%
of all AXITINIB reports
6
Deaths
7
Hospitalizations

How Dangerous Is Disseminated intravascular coagulation From AXITINIB?

Of the 10 reports, 6 (60.0%) resulted in death, 7 (70.0%) required hospitalization, and 2 (20.0%) were considered life-threatening.

Is Disseminated intravascular coagulation Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AXITINIB. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does AXITINIB Cause?

Death (2,222) Diarrhoea (2,187) Fatigue (1,816) Neoplasm progression (1,315) Hypertension (1,146) Off label use (1,075) Nausea (955) Decreased appetite (920) Dysphonia (871) Disease progression (768)

What Other Drugs Cause Disseminated intravascular coagulation?

PREDNISOLONE (362) METHOTREXATE (347) DEXAMETHASONE (323) METHYLPREDNISOLONE (307) NIVOLUMAB (305) CYCLOPHOSPHAMIDE (286) TACROLIMUS (278) PREDNISONE (277) VINCRISTINE (245) OXALIPLATIN (231)

Which AXITINIB Alternatives Have Lower Disseminated intravascular coagulation Risk?

AXITINIB vs AZACITIDINE AXITINIB vs AZATHIOPRINE AXITINIB vs AZD-1222 AXITINIB vs AZELAIC ACID AXITINIB vs AZELASTINE

Related Pages

AXITINIB Full Profile All Disseminated intravascular coagulation Reports All Drugs Causing Disseminated intravascular coagulation AXITINIB Demographics